Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connor Johnson

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2025
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving ChemoimmunotherapyP Connor Johnson, Jeremy S Abramson, Ann S LaCasce, et al.
American Journal of Hematology|May 21, 2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysisAseel Alsouqi, Gulrayz Ahmed, Juntian Wang, et al.
Blood Neoplasia|June 2, 2025
Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational studyPriyanka Pullarkat, Matthew Lei, Robert Redd, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Journal of Geriatric Oncology|June 17, 2023
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemiaP Connor Johnson, Jennifer A Woyach, Angela Ulrich, et al.
Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Molecular Psychiatry|March 5, 2022
Highly unstable heterogeneous representations in VIP interneurons of the anterior cingulate cortexConnor Johnson, Lisa N Kretsge, William W Yen, et al.
Blood|October 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationAnita Kumar, Jacob Soumerai, Jeremy S Abramson, et al.
Blood Advances|October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell LymphomaJ Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Blood Advances|October 21, 2021
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysisMehdi Hamadani, Ajay K Gopal, Marcelo Pasquini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2025
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving ChemoimmunotherapyP Connor Johnson, Jeremy S Abramson, Ann S LaCasce, et al.
American Journal of Hematology|May 21, 2024
Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysisAseel Alsouqi, Gulrayz Ahmed, Juntian Wang, et al.
Blood Neoplasia|June 2, 2025
Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational studyPriyanka Pullarkat, Matthew Lei, Robert Redd, et al.
Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Journal of Geriatric Oncology|June 17, 2023
Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemiaP Connor Johnson, Jennifer A Woyach, Angela Ulrich, et al.
Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Molecular Psychiatry|March 5, 2022
Highly unstable heterogeneous representations in VIP interneurons of the anterior cingulate cortexConnor Johnson, Lisa N Kretsge, William W Yen, et al.
Blood|October 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationAnita Kumar, Jacob Soumerai, Jeremy S Abramson, et al.
Blood Advances|October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell LymphomaJ Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Pageof 11